Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

38.03 -1.40 (-3.55%)
Streaming Delayed Price Updated: 3:18 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,173,979
Open 39.34
Bid (Size) 38.00 (1)
Ask (Size) 38.06 (1)
Prev. Close 39.43
Today's Range 37.85 - 39.46
52wk Range 12.93 - 43.32
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher
TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher. 
Via Benzinga
How does TG THERAPEUTICS INC (NASDAQ:TGTX) stack up against Mark Minervini’s strategy?
A fundamental and technical analysis of (NASDAQ:TGTX): Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing? 
Via Chartmill

Performance

YTD
+22.4%
+22.4%
1 Month
+10.5%
+10.5%
3 Month
+20.9%
+20.9%
6 Month
+62.6%
+62.6%
1 Year
+157.5%
+157.5%

More News

Read More
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.
Via Chartmill
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
Via Benzinga
Why TG Therapeutics Stock Was Soaring This Week
Via The Motley Fool
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
A Closer Look at TG Therapeutics's Options Market Dynamics
Via Benzinga
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
Via Stocktwits
Stocks Pivot Lower On Trade Fears, Manufacturing Data
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Earnings Scheduled For March 3, 2025
Via Benzinga
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With TG Therapeutics Stock Tuesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
Via Investor's Business Daily
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
AI Stocks Meta, Oracle Lead Five Names Near Buy Points
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX.
Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 38.03
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 04/01/25 03:18 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 5.87B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.